Understanding your role as a leader in creating a resilient and healthy culture is a foundation for implementing effective ...

Company’s first development candidate in autoimmune and inflammatory disease (AIID) demonstrates potent blockade of IL-4, IL-13, and IL-33 signaling pathways critical in respiratory inflammationNovel ...

With the rise of sustainability, more artists and creatives are thinking about their impact on the planet. Art is evolving, and so are the tools and processes to create it. One area seeing a big shift ...

Treatment practices in the U.S. show approximately 75% of diagnosed pulmonary sarcoidosis patients require treatment with steroids.

Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases ...

Qatar Airways posted a 28% jump in annual net profit to a record 7.8 billion Qatari riyals ($2.1 billion), according to a ...